About: Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.22 (+2.52%)
ALZN NASDAQ Alzamend Neuro Inc
Alzamend Neuro Inc share price
Atividade de preço de ALZN
Último preço
$ 1,220
Variação (24h)
0,03 USD (2,52%)
Volume
15.74K
Volume (média 4 sem.)
-
Abertura
$ 1,37
Variação do dia
$ 1,20 - $ 1,37
Fechamento anterior
$ 1,19
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
ALZN price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals